Peroxisome proliferators (PxPs) are structurally diverse compounds, such as fibrates (hypolipidemic drugs), phthalate ester plasticizers, fatty acid analogues, cause induction of several proteins related to lipid metabolism, including peroxisomal b-oxidation (Px-ox), 1, 2) accompanied by a hypolipidemic effect in rodents.
Peroxisome proliferators (PxPs) are structurally diverse compounds, such as fibrates (hypolipidemic drugs), phthalate ester plasticizers, fatty acid analogues, cause induction of several proteins related to lipid metabolism, including peroxisomal b-oxidation (Px-ox), 1, 2) accompanied by a hypolipidemic effect in rodents. 3) Since the peroxisome proliferatoractivated receptors (PPARs), which are nuclear transcriptional receptors, 4) were found, they have been regarded as the wide lipid metabolism regulatory factors. Among the 3 subtypes of PPARs, a, b/d and g, PPARa is mainly involved in peroxisome proliferation, fatty acid b-oxidation, and plasma lipid metabolism, and is expressed predominantly in the livers and kidneys of rodents. 5) On hypolipidemic action, plasma triglyceride (TG) lowering effect of PxPs, which are PPARa ligands, are responses produced by PPARa-mediated transcriptional regulation. [6] [7] [8] However, in a contrasting line of studies, the TG lowering effect of PxPs was found to be exerted by a mechanism independent of PPARa. [9] [10] [11] Thus, the mechanism of the hypolipidemic effect of PxPs has not been clearly established. Further, the implications of the two different and simultaneous responses by PxPs, which develop in a distant and distinct tissues, and their mechanisms, including physiological aims, and if it were, which is the initiator of another response, have not been elucidated.
The plasma TG lowering effect of PxPs have been essentially ascribed to the induction of lipoprotein lipase (LPL) expression 12) and the inhibition of apolipoprotein C-III (apo C-III) gene transcription and activity. 13, 14) The combined effects of PxPs toward LPL and apo C-III result in TG hydrolysis. On the other hand, fibrates induce fatty acid transporter protein in rat livers, 15) by which hepatic uptake of fatty acids is enhanced. A linear increasing correlation between Px-ox activity and cellular long chain fatty acid level by PxP was reported in rat cultured hepatocytes, 16) leading to hepatic TG accumulation when the TG synthesis process was completed, as well as a fibrate and a long chain fatty acid enhanced cellular TG level with a increase in Px-ox activity. 17) In in vivo experiments, PxPs including fatty acid analogues enhanced hepatic TG accumulation, 11, 18, 19) or in contrast, decrease it, [20] [21] [22] when the increase in Px-ox activity and the decrease in plasma TG were simultaneously observed. These discrepancy results could be due to the fact that physiological lipid metabolism is regulated by complicated, precise, and divers endogenous factors. Since the direct action of PxPs toward rat hepatocytes has been established, 23) we investigated the interrelationships among Px-ox activity, TG and apolipoprotein B (apo B) fluctuations in primary cultured rat hepatocytes in the present study, avoiding in vivo complex situations, especially hormonal modulations, organ-organ interrelation, moiety of blood components, physiological status and food intake. Apolipoprotein B (apo B) Detection VLDL fractions were obtained by a density ultracentrifugation method from 2 ml of conditioned medium at the end of the culture periods. Briefly, the medium was mixed with 0.03% benzamidine and 5% Fat Red solution, then placed into tubes, and layered with a NaCl solution adjusted to a density of 1.006 g/ml and centrifuged at 50000 rpm for 20 h at 16°C. The VLDL fractions were then concentrated 5-fold by molecular cut centrifugation (Kurabo, Japan) and subjected to SDS-PAGE on a 2-15% gradient gel (Multigel: Daiichi Pure Chemicals, Japan), after which Western blot analysis was performed using goat anti-human apolipoprotein B antibody as the first antibody, and rabbit anti-goat IgG HRP-labeled antibody as the second antibody. Cell homogenates containing 0.03% benzamidine were centrifuged to remove cell debris and the supernatants were incubated with protein A-Sepharose for 1 h at 4°C, then centrifuged at 12000 rpm at 4°C. The resultant supernatants were individually mixed with the first antibody for 2.5 h at 4°C, then protein A-Sepharose was added, and they were shaken for 1 h and centrifuged. The thoroughly washed precipitates were subjected to SDS-PAGE as the same as VLDL-apoB.
MATERIALS AND METHODS

Materials
Biological Determinations For peroxisomal b-oxidation activity, cell homogenates in 50 mM Tris-HCl buffer (pH 8.0) were subjected to enzyme determination according to 14 C-labeled acetyl CoA production from 14 C-palmitoyl CoA, using the method of Lazarow. 25) Microsome fractions, and enzyme sources were prepared for 1,2-diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) activities according to the report of Wetterau et al. 26) Cells from 5 dishes were homogenized in 50 mM Tris-HCl buffer containing 50 mM KCl, 5 mM EDTA and 0.03% benzamidine, then the homogenates were incubated with deoxycholate for 30 min at 4°C and centrifuged at 103000ϫg for 60 min. The supernatants were dialyzed against 15 mM Tris-HCl buffer with 40 mM NaCl, 1 mM EDTA and 0.03% benzamidine (15/40 buffer), and the resulting dialysates were used as enzyme solutions. DGAT activity was determined by measuring the counts of incorporated 14 C-palmitoyl CoA into the TG fraction extracted with a heptane-isopropanol-H 2 SO 4 mixture, using the method of Hosaka et al. 27) MTP activity was determined by measuring the amount of radiolabeled TG transferred from donor small unilamellar vesicles (SUVs) to acceptor SUV. To prepare the SUVs, egg phosphatidyl choline, 14 C-radiolabeled TG, cardiolipin for the donor, and egg phosphatidyl choline, unlabeled TG for the acceptor, were dissolved in chloroform, then evacuated and sonicated in 15/40 buffer for 60 min at 50°C. According to the method of Wetterau et al., 28) a typical transfer reaction mixture containing donor, acceptor vesicles, bovine serum albumin and enzyme solution in 1 ml of reaction mixture was reacted for 1 h at 37°C. The reaction was terminated by the addition of DEAE-sepharose CL-6B. The mixture was then agitated for 5 min in an ice-bath and centrifuged, and the counts in 0.5 ml of each supernatant were determined. The activity is expressed as radioactive counts per mg of protein. For TG determination, enzymatic analysis was employed using a commercial kits (Wako Pure Chemical Ind., Japan), with some modifications. Protein was measured using a DC protein assay (BIO-RAD) with bovine serum albumin as the standard.
RESULTS
Relationship between Px-ox Activity and TG The correlation between Px-ox activity and TG in cultured rat hepatocytes was examined. Addition of Nf, a PxPs, to the culture medium increased either enzyme activity or cellular TG time-dependently, whereas TG in the medium was decreased in the same manner (Fig. 1) . The relationship between the activity and cellular TG was summarized with a correlation coefficient of rϭ0.918 (Fig. 3A) , and a linear negative correlation between the activity and TG in medium with a coefficient of rϭϪ0.817 was observed (data not shown). As shown in Fig. 2 , not only Nf but also other structurally diverse PxPs, clofibrate, DEHP and Wy 14,643, produced the same relationship between the activity and cellular TG, which was summerized with a coefficient of rϭ0.747 (Fig. 3B) . Although a enhancement of hepatocellular TG level by bezafi-brate treatment in rat cultured hepatocytes was shown in a previous report, 17) an obvious relationship between Px-ox activity and TG fluctuation was shown in the present study. Total TG amount, hepatic TGϩTG in medium, in each treatment was not significantly different as compared to total TG in the control cells (data not shown). Figure 4 shows the results when hepatocytes were treated with the non-PxP pravastatin. TG level in medium was decreased, whereas cellular TG and Px-ox activity were not affected. Therefore, it is suggested that hepatic TG accumulation associated with the increase in Px-ox activity is specific action of PxPs. In order to investigate the relationship between TG accumulation and Px-ox activity, hepatocytes were treated with Brefeldin A, a blocker of Golgi apparatus function.
29) Figure 5 shows that Brefeldin A markedly increases cellular TG content, however, Px-ox activity was not enhanced.
Effect of Nf on TG Synthesis and VLDL Assembly in Hepatocytes To confirm whether PxPs increase TG synthesis activity in hepatocytes, the effect of Nf on the activity of DGAT, the last enzyme in TG de novo synthesis, was investigated. Microsome fractions prepared from cell homogenates were used as the enzyme source, and an increase in the activity that was dependent on the amount of protein was confirmed. The results presented in Fig. 6 show that 0.1 mM Nf did not have an effect on enzyme activity. Also, in regards to TG secretion from hepatocytes, microsomal triglyceride transfer protein (MTP) 30) activity, which is required for VLDL construction, was examined. As shown in Fig. 7 , enzyme activity after 24 and 48 h of culture was not significantly influenced by Nf.
Effect of Nf on apo B Since apo B is a pivotal protein during construction of VLDL particles, of which TG is a constituent and is secreted from hepatocytes to the vascular stream as particles, we examined the effect of Nf on the protein. Hepatocytes were cultured with Nf for various periods, and apo B masses in hepatocytes and media were developed by immunoblotting. The VLDL-apo B100 profiles of Nftreated media were evidently slighter than the control after 48 and 72 h of culture, and cellular apo B100 amounts following Nf treatment were larger than in the control culture. In contrast to apo B100, cellular and medium apo B48 profiles were not affected by Nf. These results reflected the results of TG fluctuations, as shown in Figs. 1 and 2 , and was very similar to the report of Linden et al. 31) DISCUSSION From the viewpoint that PPARa is expressed in hepatocytes 4) and is an indispensable transcription factor involved in primarily lipid metabolism, the effects of the exogenous ligands of PPARa, PxPs, on TG fluctuation were investigated.
The relationship between TG fluctuation and peroxisomal induction, including the peroxisome proliferation, the induction of several proteins, and increase in enzyme activities by PxPs, has not been fully elucidated, though an increase in Pxox activity and a reduction in hepatic TG level, 9, 22) or contrarily, the activity and hepatic TG accumulation 11, 18, 19) in vivo have been reported. Two mechanisms of Px induction 32) have been proposed: 1) the receptor mediated theory, termed PPARs by Isseman et al., 4) which does not rule out the possibility that PxPs interact indirectly with the receptor, and 2) substrate overload, termed lipid pertubation, which is caused by a high cellular level of long acyl CoA 20) and PxP metabolites, the corresponding CoA thioesters. 33) As for the latter, when peroxisomes are induced by exogenous PxPs, not by fatty acid analogues, which are destined to be physiologically metabolized, cellular TG status were studied in present studies.
Of the 2 major types of hypolipidemic drugs, statins and fibrates, it is widely acceptable for lowering plasma lipids in clinical pharmacology that statins, which are inhibitor for HMG CoA reductase a key enzyme in the steps of cholesterol synthesis, are applied to lower plasma cholesterol, while fibrates are aimed to lower TG. Additionally, statins and fibrates have a simultaneous potency to decrease TG and cholesterol, respectively. However, simvastatin administration to rats decreased TG concentration, due to increase in LPL mRNA and activity, accompanied by decrease in the mRNA as well as plasma apo C-III protein, 34) as well as PxPs. [12] [13] [14] Moreover, a recent study showed that lipid modulating functions of statins are through mechanism involving PPARa. 35, 36) There are several studies that hepatic peroxisomal inductions and the TG lowering effect by fibrates are not directly related. [8] [9] [10] According to a report by Foxworthy et al., 19) the sequence of events in the liver after administration of PxPs to rats, including transient hepatic TG accumulation in the early stage, followed by an increase in Px-ox, implies that hepatic TG accumulation is responsible for the induction of Px-ox. However, hepatic lipid accumulation by chlorpromazine administration resulted in no indication of Px-ox activity in rats, 37) in accordance with the results of Brefeldin A treatment (Fig. 5) . Therefore, it is suggested that hepatic TG accumulation has no responsibility for increasing Px-ox activity and lowering plasma TG both in vivo and in vitro.
The mechanism of the plasma TG lowering effect by fibrates has been ascribed to decrease in apo C-III expression 13, 14) and induce LPL gene expression in rat liver. 12) Although LPL is functional on the surface of endothelial cells in blood vessels, the enzyme is synthesized in the parenchymal cells in adipose tissues and muscle, hepatic Kupffer cells and macrophages in the lung and spleen, 38) though its synthetic potency and activity in the liver is very low in adults. 12, 39) Since fibrates have a direct effect on intracellular events in cultured hepatocytes, it is generally agreed that TG fluctuation and Px induction by PxPs are not mediated by LPL or hormones, and that the lower level of induction in isolated cells is due to a lack of several endogenous components. Even if the TG lowering effects of PxPs in vivo are due to an increase of hepatic uptake of TG or enhancement of LPL activity, the relationship between TG and Px-ox remains controversial, because animal strain, age, food intake, and circadian rhythm must also be taken into consideration.
Hepatic TG accumulation by Nf could be due to 3 phenomena in the liver, 1) enhancement of TG synthesis, 2) inhibition of TG secretion, and 3) decrease in TG degradation. Since long chain fatty acids are accumulated in rat hepatocytes following treatment with PxPs, 16) hepatic DGAT activity that catalyzes the final reaction in TG synthesis was examined. A previous study showed that fibrates raised overt (cytosol-facing) DGAT activity and inhibited latent (endoplasmic reticulum lumen-facing) DGAT activity, 40) thus even if the apparent activity was not affected by Nf treatment using microsomal fractions, as the enzyme source, we considered that the results on DGAT (Fig. 6 ) might be acceptable as a rough estimation. In previous in vivo studies, however, a linear correlation between DGAT activity and hepatic TG content was observed. 18) Apo B-containing VLDL is the responsible particle for TG secretion from the liver. Further, during intrahepatic VLDL construction, assembly of apo B with TG to form the particles requires the function of MTP. [41] [42] [43] MTP locates in the lumen of the ER of hepatocytes, then transports TG from the ER membrane, where lipid molecules are synthesized, to within the lumen of the ER. 44) In a recent study, Wy 14,643 increased the mRNA expression of MTP protein, and enhanced the activity. 45) This report, however, implies that TG secretion from hepatocytes might be stimulated as the results of enhancement of VLDL assembly by Wy 14,643, in spite of its hypolipidemic action. As shown in Fig. 8 , the fluctuation of apo B100 exactly reflected the decrease in TG in the medium and increase in cellular TG. Thus, cellular TG amounts and apo B protein in hepatocytes might be provided to secrete or to form VLDL particles.
The involvement of hepatocellular triglyceride hydrolase (hepatic triglyceride lipase HTGL) in cellular TG level remains to be studied, though the enzyme function has not been well established. With regard to TG hydrolysis in the liver, the PPAR agonist, clofibrate and fatty acid enricheddiets did not have effects on hepatic TG hydrolysis in mice. 46) In the present study, HTGL activity using conditioned media from heparin-treated cells was not different between Nf treated and control cells (data not shown).
In summary, PxPs induce hepatic TG accumulation associated with increase in Px-ox activity with a linear correlation in cultured hepatocytes. Based on our results, we concluded the following as reasons for the hepatocellular TG accumulation. Fatty acid transporter up-regulation by PxPs 15) increases the influx of fatty acids to hepatocyes. 16) Though TG is normally synthesized utilizing the transported fatty acids, TG is accumulated in hepatocytes due to the inhibition of VLDL secretion by PxPs, which is consistent with the report of Schoonjans et al., 6) leading to a lowering TG in the medium. Together with the results of recent studies on the regulation of membrane efflux transporters in the ABC family by PxPs, such as ABCA1 in intestines by Wy 14,643 47) and multidrug resistance-associated proteins in the liver by clofibrate, 48) it is hypothesized that hepatocellular membrane molecules or structures related to VLDL secretion might be modified by PxPs.
